

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.19579623 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.05884368 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.05884368 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.05884368 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.05884368 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.05884368 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.05884368 |
| 8 | response to peptidoglycan (GO:0032494) | 4.96326302 |
| 9 | respiratory burst (GO:0045730) | 4.36940475 |
| 10 | cellular extravasation (GO:0045123) | 4.03879493 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 3.99662692 |
| 12 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98295383 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.95304119 |
| 14 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.94503396 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.91868372 |
| 16 | neutrophil activation (GO:0042119) | 3.91463074 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82997153 |
| 18 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.82402298 |
| 19 | leukocyte aggregation (GO:0070486) | 3.80497582 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80071909 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.79022739 |
| 22 | granulocyte activation (GO:0036230) | 3.73061713 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.67573655 |
| 24 | superoxide anion generation (GO:0042554) | 3.61768038 |
| 25 | response to host immune response (GO:0052572) | 3.58865878 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58865878 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 3.58291475 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 3.57682922 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56466885 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.56466885 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.54454192 |
| 32 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.51763737 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.51276732 |
| 34 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.49267231 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 3.47395922 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.42375749 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.38968371 |
| 38 | regulation of mast cell activation (GO:0033003) | 3.38481757 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35164877 |
| 40 | * regulation of T-helper 1 cell differentiation (GO:0045625) | 3.34658708 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.32748026 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.29125549 |
| 43 | positive regulation of mast cell degranulation (GO:0043306) | 3.28949780 |
| 44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.28949780 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.25474269 |
| 46 | positive regulation of type 2 immune response (GO:0002830) | 3.24069561 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24001993 |
| 48 | mature B cell differentiation (GO:0002335) | 3.23606896 |
| 49 | defense response to protozoan (GO:0042832) | 3.21188042 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 3.20974488 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.19762856 |
| 52 | response to host (GO:0075136) | 3.19681843 |
| 53 | response to host defenses (GO:0052200) | 3.19681843 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19681843 |
| 55 | myeloid dendritic cell differentiation (GO:0043011) | 3.18137103 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17578333 |
| 57 | response to fungus (GO:0009620) | 3.16756494 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.16356570 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15097625 |
| 60 | T-helper 1 type immune response (GO:0042088) | 3.14294936 |
| 61 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.11672986 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10225009 |
| 63 | regulation of chemokine biosynthetic process (GO:0045073) | 3.10074942 |
| 64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.09569044 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.09420277 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.08702921 |
| 67 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07926270 |
| 68 | regulation of growth of symbiont in host (GO:0044126) | 3.07926270 |
| 69 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07926270 |
| 70 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07926270 |
| 71 | detection of other organism (GO:0098543) | 3.07380686 |
| 72 | cellular response to zinc ion (GO:0071294) | 3.07364411 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.05290286 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 3.04799365 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03352627 |
| 76 | microglial cell activation (GO:0001774) | 3.03096926 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.00986426 |
| 78 | response to protozoan (GO:0001562) | 2.97733616 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97525610 |
| 80 | regulation of vitamin metabolic process (GO:0030656) | 2.96734742 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.95378029 |
| 82 | type I interferon signaling pathway (GO:0060337) | 2.95378029 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95167755 |
| 84 | response to type I interferon (GO:0034340) | 2.94912009 |
| 85 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.94126008 |
| 86 | response to interferon-beta (GO:0035456) | 2.93793725 |
| 87 | pinocytosis (GO:0006907) | 2.91084152 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88311330 |
| 89 | regulation of podosome assembly (GO:0071801) | 2.88197920 |
| 90 | * regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87924635 |
| 91 | B cell mediated immunity (GO:0019724) | 2.87471501 |
| 92 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87245008 |
| 93 | macrophage activation (GO:0042116) | 2.85491718 |
| 94 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85389120 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.83124669 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.83094913 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.83094913 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82425368 |
| 99 | negative regulation of mast cell activation (GO:0033004) | 2.82385897 |
| 100 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.82156456 |
| 101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82108151 |
| 102 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.81964937 |
| 103 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81445459 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.79438717 |
| 105 | regulation of interleukin-12 production (GO:0032655) | 2.79069107 |
| 106 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.79025473 |
| 107 | negative regulation of interleukin-6 production (GO:0032715) | 2.78646852 |
| 108 | positive regulation of heat generation (GO:0031652) | 2.78065064 |
| 109 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.76541859 |
| 110 | cellular response to interferon-beta (GO:0035458) | 2.76439563 |
| 111 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.76036310 |
| 112 | germinal center formation (GO:0002467) | 2.75660531 |
| 113 | detection of bacterium (GO:0016045) | 2.75622465 |
| 114 | cellular response to lipopolysaccharide (GO:0071222) | 2.75271829 |
| 115 | regulation of chronic inflammatory response (GO:0002676) | 2.74627959 |
| 116 | positive regulation of interleukin-6 production (GO:0032755) | 2.74252631 |
| 117 | tooth mineralization (GO:0034505) | 2.74250640 |
| 118 | leukotriene metabolic process (GO:0006691) | 2.74246298 |
| 119 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.74169193 |
| 120 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.73197036 |
| 121 | cellular response to molecule of bacterial origin (GO:0071219) | 2.72885647 |
| 122 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72288827 |
| 123 | actin nucleation (GO:0045010) | 2.71978574 |
| 124 | myeloid leukocyte activation (GO:0002274) | 2.71627315 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71606742 |
| 126 | * regulation of type 2 immune response (GO:0002828) | 2.71366184 |
| 127 | regulation of interleukin-6 production (GO:0032675) | 2.70991812 |
| 128 | negative regulation of granulocyte differentiation (GO:0030853) | 2.70200421 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.70000867 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69118344 |
| 131 | reactive oxygen species biosynthetic process (GO:1903409) | 2.68528479 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.68277878 |
| 133 | macrophage differentiation (GO:0030225) | 2.67977134 |
| 134 | dendritic cell differentiation (GO:0097028) | 2.65401775 |
| 135 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64584652 |
| 136 | neutrophil chemotaxis (GO:0030593) | 2.63554958 |
| 137 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63207028 |
| 138 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.61398756 |
| 139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.60601376 |
| 140 | cellular response to exogenous dsRNA (GO:0071360) | 2.60396521 |
| 141 | positive regulation of interferon-beta production (GO:0032728) | 2.60381790 |
| 142 | leukocyte mediated cytotoxicity (GO:0001909) | 2.60194794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.97910934 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.45094599 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.72526552 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91660567 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.86911935 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85101698 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.51232910 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40324603 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.34388368 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.33835754 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26003934 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.22274035 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.10373043 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02069995 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88931279 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.73264375 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67264241 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53972501 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53961360 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47178014 |
| 21 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.47009304 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46521861 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.45450126 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28993785 |
| 25 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.23252386 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22667954 |
| 27 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.21466770 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07588594 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.06942571 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01830423 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00178963 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92966746 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.88777304 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88100245 |
| 35 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.82387017 |
| 36 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75925617 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75162596 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73847006 |
| 39 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73080266 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69958768 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67300740 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65296252 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64104945 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62748313 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61521280 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58812184 |
| 47 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58444518 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.56004396 |
| 49 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52612670 |
| 50 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51072098 |
| 51 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50403853 |
| 52 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.49821036 |
| 53 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49687486 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49275592 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45234375 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45018248 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44857201 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42062228 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38939609 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37944284 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37912828 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36557316 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35342563 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34033298 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32891054 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32332121 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.25118748 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24478899 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22366872 |
| 70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21078765 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15335547 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15232205 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14871248 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14695461 |
| 75 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14575519 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14389140 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13115223 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.12047446 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11288185 |
| 80 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11179354 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08570206 |
| 82 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08564440 |
| 83 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07242679 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06695556 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06428717 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05151128 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04065089 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01372859 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99419324 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95796164 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95610026 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94998126 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92825083 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92283687 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91615919 |
| 96 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91369773 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88711774 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88488929 |
| 99 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86212585 |
| 100 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.86082136 |
| 101 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85731204 |
| 102 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85419976 |
| 103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.82952799 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82739733 |
| 105 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.82366334 |
| 106 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.82150705 |
| 107 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.82150705 |
| 108 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.82150705 |
| 109 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.75953372 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74255530 |
| 111 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.74051153 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73462018 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71377107 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70366519 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68865171 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67800764 |
| 117 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67625518 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67315687 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.67081811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.64294420 |
| 2 | MP0003436_decreased_susceptibility_to | 3.54690548 |
| 3 | MP0003303_peritoneal_inflammation | 3.53604406 |
| 4 | MP0009785_altered_susceptibility_to | 3.28192585 |
| 5 | MP0003724_increased_susceptibility_to | 3.16048663 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.05874742 |
| 7 | MP0002419_abnormal_innate_immunity | 2.90225061 |
| 8 | MP0005025_abnormal_response_to | 2.73564449 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.69994582 |
| 10 | MP0000685_abnormal_immune_system | 2.63375016 |
| 11 | MP0009278_abnormal_bone_marrow | 2.55048131 |
| 12 | MP0001790_abnormal_immune_system | 2.49264130 |
| 13 | MP0005387_immune_system_phenotype | 2.49264130 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.45218318 |
| 15 | MP0004510_myositis | 2.41765925 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 2.40569238 |
| 17 | MP0001800_abnormal_humoral_immune | 2.39734953 |
| 18 | MP0002723_abnormal_immune_serum | 2.25554712 |
| 19 | MP0005671_abnormal_response_to | 2.24413837 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.21074500 |
| 21 | MP0001819_abnormal_immune_cell | 2.15978626 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.14844005 |
| 23 | MP0006082_CNS_inflammation | 2.03887768 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.99189348 |
| 25 | MP0002405_respiratory_system_inflammati | 1.98316252 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.96636320 |
| 27 | MP0000343_altered_response_to | 1.95488751 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.94443661 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.92433066 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.92433066 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.91585775 |
| 32 | MP0001853_heart_inflammation | 1.90855212 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.87263799 |
| 34 | MP0003828_pulmonary_edema | 1.82848952 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.82785297 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.69771805 |
| 37 | MP0008004_abnormal_stomach_pH | 1.66271330 |
| 38 | MP0009840_abnormal_foam_cell | 1.64174849 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.62486363 |
| 40 | MP0000716_abnormal_immune_system | 1.62090742 |
| 41 | MP0002398_abnormal_bone_marrow | 1.60436473 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.58813064 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.56794721 |
| 44 | MP0000604_amyloidosis | 1.55779293 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.54664258 |
| 46 | MP0009764_decreased_sensitivity_to | 1.53246428 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.52053790 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.50463472 |
| 49 | MP0003448_altered_tumor_morphology | 1.50145289 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.47428322 |
| 51 | MP0002006_tumorigenesis | 1.47121270 |
| 52 | MP0001879_abnormal_lymphatic_vessel | 1.45076321 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.43408721 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.42056815 |
| 55 | MP0001851_eye_inflammation | 1.40482381 |
| 56 | * MP0008469_abnormal_protein_level | 1.40091492 |
| 57 | * MP0002429_abnormal_blood_cell | 1.36644034 |
| 58 | MP0003075_altered_response_to | 1.36124157 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.35761649 |
| 60 | MP0003279_aneurysm | 1.34924666 |
| 61 | MP0000767_abnormal_smooth_muscle | 1.32927567 |
| 62 | MP0000858_altered_metastatic_potential | 1.32586533 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.31800867 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.24651141 |
| 65 | MP0002722_abnormal_immune_system | 1.23527026 |
| 66 | MP0002933_joint_inflammation | 1.22772861 |
| 67 | MP0000490_abnormal_crypts_of | 1.19524712 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.12937534 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.11582589 |
| 70 | MP0005310_abnormal_salivary_gland | 1.11166803 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.08303384 |
| 72 | MP0000249_abnormal_blood_vessel | 1.07432296 |
| 73 | MP0003690_abnormal_glial_cell | 1.06770583 |
| 74 | MP0002254_reproductive_system_inflammat | 1.06625692 |
| 75 | MP0004947_skin_inflammation | 1.06551150 |
| 76 | MP0008260_abnormal_autophagy | 1.05636886 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.05308973 |
| 78 | MP0002009_preneoplasia | 1.04133509 |
| 79 | MP0005390_skeleton_phenotype | 1.02935766 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.02318101 |
| 81 | MP0001958_emphysema | 0.99670526 |
| 82 | MP0002132_abnormal_respiratory_system | 0.97680056 |
| 83 | MP0005164_abnormal_response_to | 0.94822123 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.92612160 |
| 85 | MP0003136_yellow_coat_color | 0.90386385 |
| 86 | MP0001873_stomach_inflammation | 0.89777446 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.87005869 |
| 88 | MP0005409_darkened_coat_color | 0.86680883 |
| 89 | MP0001542_abnormal_bone_strength | 0.84739800 |
| 90 | MP0005165_increased_susceptibility_to | 0.84120977 |
| 91 | MP0005166_decreased_susceptibility_to | 0.83151753 |
| 92 | MP0004883_abnormal_blood_vessel | 0.81149033 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.80786323 |
| 94 | MP0004130_abnormal_muscle_cell | 0.79675920 |
| 95 | MP0003091_abnormal_cell_migration | 0.78427490 |
| 96 | MP0009763_increased_sensitivity_to | 0.78032731 |
| 97 | MP0005451_abnormal_body_composition | 0.77844030 |
| 98 | MP0003195_calcinosis | 0.75100392 |
| 99 | MP0003329_amyloid_beta_deposits | 0.74347237 |
| 100 | MP0009379_abnormal_foot_pigmentation | 0.73428738 |
| 101 | MP0003186_abnormal_redox_activity | 0.71627724 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.70006314 |
| 103 | MP0003795_abnormal_bone_structure | 0.69842962 |
| 104 | MP0008874_decreased_physiological_sensi | 0.69208786 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.69146433 |
| 106 | MP0001663_abnormal_digestive_system | 0.68845001 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.68825093 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.68248113 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.66015505 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.65339629 |
| 111 | MP0004381_abnormal_hair_follicle | 0.64852237 |
| 112 | MP0005647_abnormal_sex_gland | 0.63174653 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.62769983 |
| 114 | MP0003646_muscle_fatigue | 0.61974704 |
| 115 | MP0009697_abnormal_copulation | 0.61626149 |
| 116 | MP0003866_abnormal_defecation | 0.61462821 |
| 117 | MP0000609_abnormal_liver_physiology | 0.59915360 |
| 118 | MP0000920_abnormal_myelination | 0.59492592 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.57738608 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.57499959 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.57114902 |
| 122 | MP0005535_abnormal_body_temperature | 0.56372423 |
| 123 | MP0006054_spinal_hemorrhage | 0.55539221 |
| 124 | MP0005023_abnormal_wound_healing | 0.55467680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.65376009 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.05368071 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.78562692 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82003052 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.67685077 |
| 6 | Spontaneous hematomas (HP:0007420) | 4.29719709 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.27051109 |
| 8 | Obstructive lung disease (HP:0006536) | 4.26381136 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.26381136 |
| 10 | Myositis (HP:0100614) | 4.25824280 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.25446276 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 4.12743151 |
| 13 | Recurrent skin infections (HP:0001581) | 4.00594909 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.87162639 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.73037229 |
| 16 | Loss of speech (HP:0002371) | 3.72439987 |
| 17 | Orchitis (HP:0100796) | 3.65313267 |
| 18 | Stomatitis (HP:0010280) | 3.42885260 |
| 19 | Cellulitis (HP:0100658) | 3.36576470 |
| 20 | Meningitis (HP:0001287) | 3.32644349 |
| 21 | Disinhibition (HP:0000734) | 3.27157479 |
| 22 | Glomerulonephritis (HP:0000099) | 3.21240835 |
| 23 | Petechiae (HP:0000967) | 3.20496629 |
| 24 | Hematochezia (HP:0002573) | 3.20359214 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19997841 |
| 26 | Gingivitis (HP:0000230) | 3.14985244 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14652447 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14652447 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.03525172 |
| 30 | Recurrent viral infections (HP:0004429) | 3.00206845 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.98840342 |
| 32 | Optic neuritis (HP:0100653) | 2.98840342 |
| 33 | Urticaria (HP:0001025) | 2.89238845 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.83263939 |
| 35 | Chronic otitis media (HP:0000389) | 2.81307936 |
| 36 | Vasculitis (HP:0002633) | 2.80314406 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.76063465 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.76063465 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.76063465 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.74523947 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74087549 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.71847656 |
| 43 | Mutism (HP:0002300) | 2.70885533 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.69264081 |
| 45 | Basal ganglia calcification (HP:0002135) | 2.68203369 |
| 46 | Increased serum ferritin (HP:0003281) | 2.66580020 |
| 47 | Thrombocytosis (HP:0001894) | 2.64268336 |
| 48 | Polycythemia (HP:0001901) | 2.58532022 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.56835521 |
| 50 | Reduced antithrombin III activity (HP:0001976) | 2.55353648 |
| 51 | Nuclear cataract (HP:0100018) | 2.52810272 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.51652445 |
| 53 | Hemoptysis (HP:0002105) | 2.49460302 |
| 54 | Epistaxis (HP:0000421) | 2.46115653 |
| 55 | Microcytic anemia (HP:0001935) | 2.44901715 |
| 56 | Leukocytosis (HP:0001974) | 2.44434609 |
| 57 | Gangrene (HP:0100758) | 2.43176044 |
| 58 | Episodic fever (HP:0001954) | 2.43110635 |
| 59 | Gingival bleeding (HP:0000225) | 2.39570805 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.38484330 |
| 61 | Arterial thrombosis (HP:0004420) | 2.36957391 |
| 62 | Periodontitis (HP:0000704) | 2.34002419 |
| 63 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33810986 |
| 64 | Colitis (HP:0002583) | 2.33582593 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.32707548 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.32533593 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.32092547 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.28935861 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.28285402 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.26682850 |
| 71 | Polyneuropathy (HP:0001271) | 2.25148926 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.24043417 |
| 73 | Purpura (HP:0000979) | 2.23874134 |
| 74 | Peritonitis (HP:0002586) | 2.22889102 |
| 75 | Myocardial infarction (HP:0001658) | 2.22421461 |
| 76 | Anorexia (HP:0002039) | 2.21980816 |
| 77 | Agammaglobulinemia (HP:0004432) | 2.17106207 |
| 78 | Osteomyelitis (HP:0002754) | 2.16945738 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16382897 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.16254581 |
| 81 | Nephritis (HP:0000123) | 2.15460208 |
| 82 | Pustule (HP:0200039) | 2.14489814 |
| 83 | Chest pain (HP:0100749) | 2.12705076 |
| 84 | Exertional dyspnea (HP:0002875) | 2.11477415 |
| 85 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.10299876 |
| 86 | Encephalitis (HP:0002383) | 2.09109684 |
| 87 | Pulmonary embolism (HP:0002204) | 2.06977226 |
| 88 | Diminished motivation (HP:0000745) | 2.06093932 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 2.05361915 |
| 90 | Pulmonary artery stenosis (HP:0004415) | 2.04768360 |
| 91 | Axonal loss (HP:0003447) | 2.04363758 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03005573 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03005573 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03005573 |
| 95 | Apathy (HP:0000741) | 2.02408779 |
| 96 | IgM deficiency (HP:0002850) | 2.02102783 |
| 97 | Increased IgE level (HP:0003212) | 2.01001577 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.00591837 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.00589265 |
| 100 | Polygenic inheritance (HP:0010982) | 2.00056864 |
| 101 | Impaired platelet aggregation (HP:0003540) | 1.99325868 |
| 102 | Abnormal platelet function (HP:0011869) | 1.99325868 |
| 103 | Complement deficiency (HP:0004431) | 1.99074831 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 1.97849920 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97122435 |
| 106 | Vertigo (HP:0002321) | 1.97070058 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 1.96101498 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95695618 |
| 109 | Eosinophilia (HP:0001880) | 1.95290047 |
| 110 | T lymphocytopenia (HP:0005403) | 1.94091526 |
| 111 | Increased IgM level (HP:0003496) | 1.94033267 |
| 112 | Nonprogressive disorder (HP:0003680) | 1.93697975 |
| 113 | Reticulocytopenia (HP:0001896) | 1.93544711 |
| 114 | Abnormality of B cell number (HP:0010975) | 1.92546332 |
| 115 | Nasal polyposis (HP:0100582) | 1.91760289 |
| 116 | Amyloidosis (HP:0011034) | 1.90392015 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.90346914 |
| 118 | Acne (HP:0001061) | 1.89964364 |
| 119 | Glomerulopathy (HP:0100820) | 1.89316548 |
| 120 | Abnormality of T cell number (HP:0011839) | 1.88483378 |
| 121 | Joint hemorrhage (HP:0005261) | 1.88039111 |
| 122 | Panhypogammaglobulinemia (HP:0003139) | 1.87106230 |
| 123 | Sepsis (HP:0100806) | 1.87043073 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.86585697 |
| 125 | Personality changes (HP:0000751) | 1.86462792 |
| 126 | Anhidrosis (HP:0000970) | 1.85199391 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.84768380 |
| 128 | Albinism (HP:0001022) | 1.84720647 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81139412 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.81139412 |
| 131 | Skin ulcer (HP:0200042) | 1.79975481 |
| 132 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79277397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.69678752 |
| 2 | IRAK4 | 3.34916854 |
| 3 | MAP3K14 | 3.10741422 |
| 4 | MAP4K1 | 2.82750051 |
| 5 | NME2 | 2.71429330 |
| 6 | TIE1 | 2.64080668 |
| 7 | TBK1 | 2.58573860 |
| 8 | TYK2 | 2.42319835 |
| 9 | TAOK2 | 2.34250211 |
| 10 | KDR | 2.30689326 |
| 11 | TGFBR2 | 2.29277218 |
| 12 | CLK1 | 2.16169742 |
| 13 | TAOK1 | 2.14521765 |
| 14 | KIT | 2.14018284 |
| 15 | IKBKB | 2.11208867 |
| 16 | RIPK4 | 2.10866193 |
| 17 | ERN1 | 2.08232787 |
| 18 | IKBKE | 2.06366060 |
| 19 | IRAK3 | 2.02432387 |
| 20 | ZAP70 | 1.96468144 |
| 21 | PRPF4B | 1.93674234 |
| 22 | TEC | 1.93395036 |
| 23 | MUSK | 1.91524631 |
| 24 | BTK | 1.80588076 |
| 25 | NLK | 1.69962459 |
| 26 | PIM2 | 1.57711901 |
| 27 | TXK | 1.51660333 |
| 28 | RPS6KA4 | 1.46361444 |
| 29 | DDR2 | 1.44102637 |
| 30 | EPHB1 | 1.43993536 |
| 31 | CSK | 1.43903162 |
| 32 | JAK3 | 1.39533908 |
| 33 | CSF1R | 1.38855249 |
| 34 | MAP3K13 | 1.37370947 |
| 35 | MAP2K3 | 1.33797158 |
| 36 | FES | 1.33194192 |
| 37 | CDC42BPA | 1.32116130 |
| 38 | PIM1 | 1.28958014 |
| 39 | RIPK1 | 1.26577884 |
| 40 | FGR | 1.26403281 |
| 41 | NTRK2 | 1.26316960 |
| 42 | TNK2 | 1.23708125 |
| 43 | CHUK | 1.15418562 |
| 44 | SYK | 1.13761521 |
| 45 | TRIB3 | 1.11376023 |
| 46 | HCK | 1.08987339 |
| 47 | LYN | 1.08660929 |
| 48 | PRKG2 | 1.08538493 |
| 49 | DYRK3 | 1.06280895 |
| 50 | GRK6 | 1.04179108 |
| 51 | GRK7 | 1.01703727 |
| 52 | MAP3K5 | 1.00298224 |
| 53 | JAK1 | 0.99437289 |
| 54 | PIK3CG | 0.98577696 |
| 55 | MAP3K11 | 0.97167059 |
| 56 | ADRBK2 | 0.92940989 |
| 57 | MOS | 0.86657684 |
| 58 | PRKD2 | 0.85730635 |
| 59 | LCK | 0.85478234 |
| 60 | YES1 | 0.82796242 |
| 61 | STK24 | 0.78973861 |
| 62 | MAP2K2 | 0.78474592 |
| 63 | TRPM7 | 0.77070651 |
| 64 | CDK9 | 0.75284865 |
| 65 | DMPK | 0.74737188 |
| 66 | STK10 | 0.74527240 |
| 67 | MAP3K1 | 0.71099309 |
| 68 | EIF2AK2 | 0.67461844 |
| 69 | LRRK2 | 0.67409890 |
| 70 | RPS6KA5 | 0.64370591 |
| 71 | BMPR2 | 0.64224929 |
| 72 | STK4 | 0.63490677 |
| 73 | MARK3 | 0.63244419 |
| 74 | MAP2K6 | 0.63237497 |
| 75 | NEK9 | 0.63196328 |
| 76 | PKN2 | 0.62817115 |
| 77 | MKNK2 | 0.62475716 |
| 78 | JAK2 | 0.62396741 |
| 79 | IRAK1 | 0.60701487 |
| 80 | RPS6KA6 | 0.60117285 |
| 81 | MATK | 0.59734061 |
| 82 | GRK1 | 0.59226326 |
| 83 | MAPKAPK2 | 0.58534926 |
| 84 | SIK3 | 0.57309987 |
| 85 | PTK2B | 0.54179237 |
| 86 | MAPK4 | 0.53370896 |
| 87 | ABL2 | 0.53298570 |
| 88 | TGFBR1 | 0.53228934 |
| 89 | PRKAA2 | 0.50882992 |
| 90 | MAP3K10 | 0.50154813 |
| 91 | PDK1 | 0.49439413 |
| 92 | PDPK1 | 0.49031240 |
| 93 | MYLK | 0.49016281 |
| 94 | MAPK7 | 0.48917748 |
| 95 | TTN | 0.48545897 |
| 96 | MKNK1 | 0.48334384 |
| 97 | PAK4 | 0.47922789 |
| 98 | CDK4 | 0.47915250 |
| 99 | ABL1 | 0.46866795 |
| 100 | PRKCD | 0.46840622 |
| 101 | HIPK2 | 0.46644868 |
| 102 | DYRK1B | 0.45624968 |
| 103 | MAP3K3 | 0.45532757 |
| 104 | ITK | 0.44599949 |
| 105 | VRK1 | 0.43903199 |
| 106 | MARK2 | 0.43567504 |
| 107 | RPS6KC1 | 0.42366825 |
| 108 | RPS6KL1 | 0.42366825 |
| 109 | CASK | 0.41706471 |
| 110 | PTK6 | 0.39779658 |
| 111 | ACVR1B | 0.38538138 |
| 112 | RPS6KA2 | 0.38279086 |
| 113 | TAOK3 | 0.36919069 |
| 114 | FLT3 | 0.36870275 |
| 115 | MAPK12 | 0.35564586 |
| 116 | CDK6 | 0.35346086 |
| 117 | CAMKK2 | 0.35180651 |
| 118 | TESK2 | 0.35014226 |
| 119 | MAP3K6 | 0.34651835 |
| 120 | KSR2 | 0.31145247 |
| 121 | ARAF | 0.29878281 |
| 122 | IRAK2 | 0.29646855 |
| 123 | GSK3A | 0.29473254 |
| 124 | FYN | 0.29264166 |
| 125 | EGFR | 0.28287563 |
| 126 | CCNB1 | 0.26970933 |
| 127 | PRKCQ | 0.25522884 |
| 128 | DAPK2 | 0.24828804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.25195769 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.97469026 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40362918 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38379870 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34479642 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27312156 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24473450 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.15358836 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.12836490 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.04036975 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02329282 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.92404396 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89817923 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89081783 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.87745936 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.85450140 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.82997666 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80293978 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78327952 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.77544431 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70917700 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.69369173 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69049220 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.67708705 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66562317 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58522340 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56540098 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.54854588 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51379165 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50801318 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50498105 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46118660 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41435711 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.40455177 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.39413322 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35424684 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35267803 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32231964 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.29701600 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25051865 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24930257 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21749978 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16202512 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15537065 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.15534561 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12946276 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12212938 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01987817 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.00915357 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.99991343 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96902970 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94393679 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92223661 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91931113 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91617757 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91551538 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.89658551 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.87740076 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85972191 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85840737 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82133512 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79221949 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78136004 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.75983004 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72794555 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69319636 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69171824 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69029347 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68649281 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.67662279 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67163527 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64018964 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62504087 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61880863 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58150263 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58025795 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57893232 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57456212 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56102984 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55708647 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.53463211 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53160093 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51732980 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50515973 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48972748 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47829833 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47072743 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45872487 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45548400 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45325299 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.44666496 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44415033 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44327689 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43383761 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.42296475 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42148578 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.40870661 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40800752 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39838967 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39826806 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39302544 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37848768 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37300312 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.37189665 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36981895 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36809371 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36621471 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35553324 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35379050 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34637495 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34252208 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34138303 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33730702 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31936456 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30932466 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30722577 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29524232 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29295749 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28441300 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28003280 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.25638253 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25468873 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23493064 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.19753718 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19309556 |

